Reporting by the Bureau of Investigative Journalism, in partnership with STAT, reveals that at least a dozen brands of the crucial childhood cancer drug, asparaginase, have been proven to be poor quality. In some cases, brands fell well below the standard needed to treat cancer, and many have also been found to contain contaminants such ...
